OVER $1 BILLION RECOVERED FOR OUR CLIENTS

To learn more about your legal options
Contact Canepa, Riedy, Abele, & Fischer Today
for a Free Consultation

Contact Us Today

Dangerous Drugs and Medical Devices

Personal Injury

Consumer Class Actions


Construction Defects

Las Vegas' Premier Law Firm

Canepa, Riedy, Abele, & Fischer

Intelligent, dedicated and successful, the lawyers at Canepa, Riedy, Abele, & Fischer have recovered more than $1 billion for consumers and injured people in Nevada and the United States. We hold corporations, insurance companies and individuals accountable for their actions. This is the guiding principle of the firm.

We do not defend corporations, businesses or insurance companies. We provide the know-how and resources to help the little guy level the playing field against the moneyed interests of those who do wrong.

Dangerous Drugs and Medical Devices We Handle

Hernia Mesh

Several complications and adverse events related to hernia mesh have been reported to the U.S. Food and Drug Administration (“FDA”). These complications include severe and persistent pain, infection, hernia recurrence, mesh shrinkage or migration.

IVC Filter

IVC filters have been linked to potentially deadly complications including a high risk that pieces of metal wire will break off and puncture the vein, migrate into the heart or lungs, and cause severe injuries.

Metal-on-Metal Prosthetic Hips

According to the U.S. Food and Drug Administration (“FDA”), metal-on-metal hip implants have unique risks not associated with other types of hip implants. For example, in metal-on-metal hip implants, friction between the ball and cup can release tiny metal particles into the space around the implant.

Taxotere

One potentially devastating side effect of Taxotere is permanent alopecia (hair loss). Although many chemotherapy drugs are known to cause temporary hair loss, with most chemotherapy drugs hair begins growing back 3 – 6 months after treatment ends.

Pradaxa (Dabigatran)

Pradaxa is known to cause severe bleeding events that may lead to disabling, life-threatening or even fatal outcomes including heart attack and stroke. Additionally, although it is intended to prevent blood clots, Pradaxa may actually cause a particularly dangerous type of blood clot in the spinal cord.

Abilify (aripiprazole)

Abilify was initially approved by the U.S. Food and Drug Administration (“FDA”) in 2002. Since then studies have shown that patients who take Abilify may develop addictive behaviors including compulsive gambling, shopping, eating, and hypersexuality.

Invokana (Canagliflozin)

Invokana was first approved by the U.S. Food and Drug Administration (“FDA”) in March 2013. Just two years later, in May 2015, the FDA issued a drug safety communication warning patients and doctors that Invokana and other SGLT2 inhibitors may lead to a serious condition called diabetic ketoacidosis (DKA).

Latest News

Results are important.

Martindale-Hubbell gives Canepa, Riedy, Abele, & Fischer an AV rating for ethics and ability – the highest rating possible.